NASDAQ: AMGN · Health Care / Biotechnology: Biological Products (No Diagnostic Substances)

Amgen Inc.

How Amgen Inc. compares with its industry, its sector and the market: price, value, growth, profit and risk.

Market cap

$249.1B

Price

$460.73

P/E

28.5

EPS (TTM)

$16.17

1-year return

57.8%

Dividend yield

2.1%

52-week range

$296.30–$460.73

Compared with

• Biotechnology: Biological Products (No Diagnostic Substances) industry
• Health Care sector
• S&P 500
• NASDAQ-100
• Dow Jones Industrial Average

For information only, not investment advice. Data may contain errors. Disclaimer · Sources